Recruiting NA INTERVENTIONAL 8-arm NCT06488118

Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

Lung Immune Challenge Study Controlled Exposure to Inhaled Resiquimod (R848) to Study Mechanisms of Inflammation

Sponsor: Akhilesh Jha

Conditions Asthma Innate Immunity Mucosal Immunity Viral Infection

Updated 2 times since 2024 Last updated: Jul 8, 2024 Started: May 24, 2024 Primary completion: May 31, 2025 Completion: Jul 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Asthma and Innate Immunity and is currently actively recruiting participants. Akhilesh Jha leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Aug 2024 — Sep 2024 [monthly]

Recruiting NA

First recorded

May 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Akhilesh Jha
University of Cambridge

Data source: Cambridge University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cambridge, United Kingdom